Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
基本信息
- 批准号:10473894
- 负责人:
- 金额:$ 53.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2025-08-31
- 项目状态:未结题
- 来源:
- 关键词:22q22q1122q11.2AffectAfricanAfrican AmericanAfrican American populationAllelesAutomobile DrivingCharacteristicsChildChildhoodChromosome 22Chromosome DeletionChromosomesComplexCopy Number PolymorphismDNADNA SequenceDataDiGeorge SyndromeDiseaseDissectionEthnic OriginEventFamilyFosteringFrequenciesGene RearrangementGeneral PopulationGenerationsGenetic PolymorphismGenetic RecombinationGenetic StructuresGenomeGenomic SegmentGenomicsGoalsHaplotypesHospitalsHuman GenomeIndividualLeadLive BirthMapsMediatingMolecularOpticsParentsPathologyPatientsPhenotypePlayPopulationPositioning AttributePrevalenceRecurrenceRisk FactorsRoleSiteStructural defectStructureSuggestionSyndromeTechnologyTestingVariantWorkbasecat eye syndromecaucasian Americancohorthomologous recombinationhuman diseaseinnovationinsightmicrodeletionnanochannelneuropsychiatrynovelnovel strategiesoffspringprobandsingle moleculewhole genome
项目摘要
Project Summary/Abstract
Numerous human diseases result from recurrent DNA rearrangements involving unstable genomic regions. They
are facilitated by the presence of region-specific low-copy repeats (LCRs) and are the result of nonallelic
homologous recombination (NAHR) between such paralogous genomic segments. The 22q11.2 region
undergoes a significant number of germline rearrangements. As such, it has been classified as one of the more
unstable regions of the human genome. The 22q11.2 deletion syndrome (22q11DS) is the most common
microdeletion disorder. It is associated with phenotypic and neuropsychiatric pathology, both of which are widely
variable. In most affected individuals, the deletion is de novo and is the result of NAHR mediated by four
chromosome22-specific low copy repeats (LCRA, -B, -C and -D) in 22q11. Their size and the presence of
numerous segments with near-identical sequence render these chromosome specific LCRs as substrates for
NAHR. Numerous genomic disorders, including the 22q11DS are the result of NAHR. LCR22s are extremely
difficult to reliably map and sequence because of their structural characteristics. Currently, an accurate reference
sequence for the region does not exist. Also, they are recalcitrant to short read sequencing such that the level
of their polymorphism and variability in the general population is unknown. However, optical mapping of the
region with Bionano Genomics' Saphyr technology overcomes this difficulty. Thus, 22q11.2 becomes a test case
for LCR delineation by optical mapping. Our preliminary optical mapping data suggests a complex organization
of duplicated 160kb modules within LCRA and LCRD, including copy number and orientation differences.
Further, a common inversion polymorphism within LCRD has been identified. Our preliminary data suggests that
this polymorphic inversion is less prevalent in African Americans (AAs), which may finally explain the relative
deficit of AAs in our CHOP-based 22q11DS cohort. We propose to employ innovative Bionano optical mapping
technology to determine the frequency of 22q11 LCR polymorphisms in the general population and explore the
role they play in facilitating rearrangements. The prevalence of the LCRD inversion in several different
populations (CEU, African, and African American subjects from the 1000 Genomes Project; local white and AA
22q11DS trios) will be determined. The LCR22-containing regions associated with 22q11DS will be examined in
these same populations to determine their structure and variation. Finally, we propose to analyze the breakpoints
of some typical and atypical 22q11.2 deletions and duplications guided by Bionano optical maps derived from
probands in the 22q11DS and duplication trios. By leveraging the increased sensitivity afforded by long single
molecule optical mapping on nanochannel arrays, this proposal will elucidate the previously unmapped structure
and variation of LCR22s and surrounding regions in greater detail. The data and maps generated herein will
provide access to many other difficult to map and sequence genomic regions and other genomic disorders.
项目摘要/摘要
许多人类疾病是由涉及不稳定基因组区域的反复DNA重排引起的。他们
通过区域特异性低拷贝重复序列(LCR)的存在而变得容易,并且是非等位基因的结果
这些相似基因组片段之间的同源重组(Nahr)。22q11.2区域
经历了大量的生殖系重排。因此,它被归类为
人类基因组的不稳定区域。最常见的是22q11.2缺失综合征(22q11DS
微缺失障碍。它与表型和神经精神病理学有关,两者都广泛存在。
变量。在大多数受影响的个体中,缺失是从头开始的,是由四个人介导的Nahr的结果
22q11中22号染色体特有的低拷贝重复序列(LCRA、-B、-C和-D)。它们的大小和存在的
许多序列几乎相同的片段使这些染色体特异的LCR作为底物
纳尔。许多基因组疾病,包括22q11DS是Nahr的结果。LCR22非常
由于它们的结构特点,很难可靠地绘制和排序。目前,一个准确的参考
该区域的序列不存在。此外,他们对短读测序的顽固性使得水平
它们在普通人群中的多态和变异性尚不清楚。然而,光学测绘
Bionano基因组公司的Sassir技术克服了这一困难。因此,22q11.2成为一个测试用例
用于通过光学测绘来划定LCR。我们的初步光学测绘数据显示
LCRA和LCRD内复制的160KB模块的数量,包括副本数量和方向差异。
此外,在LCRD中发现了一种常见的倒位多态。我们的初步数据表明
这种多态倒置在非裔美国人(AA)中不太普遍,这可能最终解释了相对的
我们基于CHOP的22q11DS队列中AAs缺乏。我们建议使用创新的Bionano光学测绘
技术检测22q11 LCR多态在普通人群中的频率并探索
它们在促进重新安排方面发挥了作用。LCRD倒置在几种不同类型中的患病率
人口(1000基因组计划中的CEU、非洲人和非裔美国人;当地白人和AA
22q11DS三联体)将被确定。将在中检查与22q11DS相关的包含LCR22的区域
这些相同的种群决定了它们的结构和变异。最后,我们建议对断点进行分析
由Bionano光学地图指导的一些典型和非典型的22q11.2缺失和复制
22q11DS和复制三重奏中的先驱。通过利用Long Single提供的更高的灵敏度
在纳米通道阵列上的分子光学映射,这一提议将阐明先前未映射的结构
以及更详细的LCR22及其周围区域的变异。此处生成的数据和地图将
提供访问许多其他难以绘制和测序基因组区域和其他基因组疾病的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BEVERLY S EMANUEL其他文献
BEVERLY S EMANUEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BEVERLY S EMANUEL', 18)}}的其他基金
Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
- 批准号:
10296523 - 财政年份:2018
- 资助金额:
$ 53.7万 - 项目类别:
Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
- 批准号:
9763601 - 财政年份:2018
- 资助金额:
$ 53.7万 - 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
- 批准号:
8690149 - 财政年份:2010
- 资助金额:
$ 53.7万 - 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
- 批准号:
8314057 - 财政年份:2010
- 资助金额:
$ 53.7万 - 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
- 批准号:
7985951 - 财政年份:2010
- 资助金额:
$ 53.7万 - 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
- 批准号:
8479435 - 财政年份:2010
- 资助金额:
$ 53.7万 - 项目类别:
2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies
2/2 22q11 缺失研究的大脑、行为和遗传研究
- 批准号:
8141258 - 财政年份:2010
- 资助金额:
$ 53.7万 - 项目类别:
Chromosomal Rearrangements and Cardiac Candidate Genes
染色体重排和心脏候选基因
- 批准号:
7354823 - 财政年份:2007
- 资助金额:
$ 53.7万 - 项目类别:
相似国自然基金
基于产前超声深度学习模型预测胎儿22q11缺失风险的应用研究
- 批准号:82302230
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Molecular Dissection of the 22q11.2 Deletion Syndrome
22q11.2 缺失综合征的分子解剖
- 批准号:
10296523 - 财政年份:2018
- 资助金额:
$ 53.7万 - 项目类别:
Cognitive-Affective Psychosis Proneness Risk and protective factors in 22q11.2DS
22q11.2DS 认知情感精神病倾向的风险和保护因素
- 批准号:
9317531 - 财政年份:2015
- 资助金额:
$ 53.7万 - 项目类别:
Cognitive-Affective Psychosis Proneness Risk and protective factors in 22q11.2DS
22q11.2DS 认知情感精神病倾向的风险和保护因素
- 批准号:
9748594 - 财政年份:2015
- 资助金额:
$ 53.7万 - 项目类别:
A novel approach for diagnosis and newborn screening for 22q11 deletion syndrome
22q11 缺失综合征诊断和新生儿筛查的新方法
- 批准号:
7921767 - 财政年份:2009
- 资助金额:
$ 53.7万 - 项目类别:
A novel approach for diagnosis and newborn screening for 22q11 deletion syndrome
22q11 缺失综合征诊断和新生儿筛查的新方法
- 批准号:
7688527 - 财政年份:2008
- 资助金额:
$ 53.7万 - 项目类别:
A novel approach for diagnosis and newborn screening for 22q11 deletion syndrome
22q11 缺失综合征诊断和新生儿筛查的新方法
- 批准号:
7533816 - 财政年份:2008
- 资助金额:
$ 53.7万 - 项目类别:
Genetic Modifiers for 22q 11.2 Deletion Syndrome
22q 11.2 缺失综合征的基因修饰剂
- 批准号:
7575145 - 财政年份:2007
- 资助金额:
$ 53.7万 - 项目类别:
Genetic Modifiers for 22q 11.2 Deletion Syndrome
22q 11.2 缺失综合征的基因修饰剂
- 批准号:
7208179 - 财政年份:2007
- 资助金额:
$ 53.7万 - 项目类别:
Genetic Modifiers for 22q 11.2 Deletion Syndrome
22q 11.2 缺失综合征的基因修饰剂
- 批准号:
7762735 - 财政年份:2007
- 资助金额:
$ 53.7万 - 项目类别:
Genetic Modifiers for 22q 11.2 Deletion Syndrome
22q 11.2 缺失综合征的基因修饰剂
- 批准号:
7343242 - 财政年份:2007
- 资助金额:
$ 53.7万 - 项目类别:














{{item.name}}会员




